# DeepScribe

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/deepscribe

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.deepscribe.ai
- Total disclosed funding: $40M
- Latest round: Series A (Oct 6, 2021)
- Investors on record: 12

## About

DeepScribe Inc., based in the US, specializes in automating medical documentation for healthcare professionals using advanced AI technology, enhancing operational efficiency and clinician-patient interactions.Founded in 2017 and headquartered in San Francisco, US, DeepScribe Inc. automates medical documentation for healthcare providers. The company has successfully raised USD 33.00 mn in its Series A funding round on October 6, 2021, led by Index Ventures, with participation from 1984 Ventures, Bee Partners, Gaingels, and Stage 2 Capital. The CEO and co-founder, Akilesh Bapu, along with Matthew Ko, established the firm to streamline the documentation process in healthcare, leveraging extensive data from over five million patient conversations.DeepScribe offers an advanced Ambient Operating System designed to automate medical documentation for healthcare providers, focusing on specialty fields such as oncology, orthopedics, and cardiology. It transforms patient-clinician conversations into accurate clinical notes, capturing essential coding information for compliance and reimbursement. The AI technology surpasses human scribes in accuracy, catering to health systems and private practices across the US, alleviating documentation burdens and enhancing clinician engagement with patients.DeepScribe operates on a subscription-based revenue model, providing healthcare organizations access to its Ambient Operating System and associated services. Clients implement DeepScribe's solutions into their workflows to streamline operations. The pricing structure accommodates various healthcare institutions, with flagship products including the AI Medical Scribe and the Customization Studio, allowing tailored documentation.Following its recent funding round in October 2021, DeepScribe plans to accelerate growth and enhance medical documentation workflows. The company aims to introduce new products designed to further streamline documentation processes for healthcare providers. Additionally, there are plans to expand into new geographic regions, targeting markets across the US where the demand for efficient care delivery is increasing.

## Funding rounds

- Series A, Oct 6, 2021, $33M — Index Ventures, Bee Partners, Gaingels, 1984 Ventures, Stage 2 Capital
- Seed, May 13, 2021, $5.2M — Hong Shan, Industry Ventures, Plug and Play, Bee Partners, Supernode Ventures, Foothill Ventures, 1984 Ventures, Skydeck DUPLICATE, Wavemaker Three-Sixty Health, Stage 2 Capital
- Seed, Sep 1, 2019, $2M — Plug and Play, Bee Partners, Supernode Ventures, Foothill Ventures, 1984 Ventures, Wavemaker Three-Sixty Health

## Investors

- Plug and Play (https://capitalatlas.ai/funds/plug-and-play) — Seed
- Bee Partners (https://capitalatlas.ai/funds/bee-partners) — Seed, Series A
- Supernode Ventures (https://capitalatlas.ai/funds/supernode-ventures) — Seed
- Foothill Ventures (https://capitalatlas.ai/funds/foothill-ventures) — Seed
- 1984 Ventures (https://capitalatlas.ai/funds/1984-ventures) — Seed, Series A
- Wavemaker Three-Sixty Health (https://capitalatlas.ai/funds/wavemaker-three-sixty-health) — Seed
- Hong Shan — Seed
- Industry Ventures (https://capitalatlas.ai/funds/industry-ventures) — Seed
- Skydeck DUPLICATE — Seed
- Stage 2 Capital — Seed, Series A
- Index Ventures (https://capitalatlas.ai/funds/index-ventures) — Series A
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series A